Page last updated: 2024-10-30

beta-lapachone and Lymphoma, Large B-Cell, Diffuse

beta-lapachone has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.

Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, SM1
Jeong, Y1
Lee, S1
Im, H1
Tae, HS1
Kim, BG1
Park, HD1
Park, J1
Hong, S1

Other Studies

1 other study available for beta-lapachone and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma.
    Journal of medicinal chemistry, 2015, Nov-12, Volume: 58, Issue:21

    Topics: Antineoplastic Agents; Caspases; Cell Line, Tumor; Cell Proliferation; Humans; Lymphoma, Large B-Cel

2015